Dermatologic adverse events in the treatment of NSCLC with amivantamab plus lazertinib significantly reduced

Consolidation durvalumab after cCRT shows decreased disease progression in LS-SCLC

Subcutaneous pembrolizumab is a viable treatment option for mNSCLC

SIOG 2024: Updates in radiation oncology

SIOG 2024: Updates in medical oncology

Ageing and cancer: Inflammation promotes ageing-associated oncogenesis in the lung

Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study

WCI's role in the prevention of tobacco related cancer among Beedi rolling women in India

Alternative livelihood training programme for rural women who are employed in the tobacco industry in India

ESMO and WCLC: Latest developments in EGFR mutated NSCLC

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation

New NK-1 inhibitor HR20013 shows promising results in preventing chemotherapy-induced nausea and vomiting in NSCLC patients